...

R&D production

R&D center mission

Develop and improve technologies for processing bioavailable extracts that preserve all the beneficial properties of nutrients and ensure their easy assimilation by the body.

Create new nutrient products
for active living and longevity.

Slide

The work of the R&D center includes both research and production of prototypes and small-batch samples of products, which allows you to qualitatively study a new product before launching it into industrial production. Scientifically proven, clinically proven, practically tested - the basic standards by which we create all our products.

Slide

In our work we use the experience of world leaders and our own unique patented developments in the production of special foods. We produce our own high quality substances and use raw materials and extracts from world-renowned manufacturers, standardized, certified and clinically tested.

Slide

The team of the R&D center is known for the development of complex nutritional products. In them we use unique raw materials (extracts), which we produce independently, according to our own original technologies and compliance with the requirements of international food safety standards NACCP / ISO 22000: 2007.

Slide

Development and release of new products begins after long research and comprehensive study of the properties of the components. With the release of the product on the market, research does not stop and lasts for many years.

R&D is a research and development center located in Kyiv region.

Slide

The work of the R&D center includes both research and production of prototypes and small-batch samples of products, which allows you to qualitatively study a new product before launching it into industrial production. Scientifically proven, clinically proven, practically tested - the basic standards by which we create all our products.

Slide

In our work we use the experience of world leaders and our own unique patented developments in the production of special foods. We produce our own high quality substances and use raw materials and extracts from world-renowned manufacturers, standardized, certified and clinically tested.

Slide

The team of the R&D center is known for the development of complex nutritional products. In them we use unique raw materials (extracts), which we produce independently, according to our own original technologies and compliance with the requirements of international food safety standards NACCP / ISO 22000: 2007.

Slide

Development and release of new products begins after long research and comprehensive study of the properties of the components. With the release of the product on the market, research does not stop and lasts for many years.

Areas of R&D activities

Product research area:

• development of functional nutritional products for preventive and dietary nutrition;

• examination of the effectiveness and prospects of proposals for new tools, treatment methods for the start of research and further implementation;

• conducting preclinical and clinical studies.

Production and research direction:

• experimental activities, development of
new technologies;

• improvement of tools, methods and technologies
production.

Efficacy has been proven by scientific research

Research partners in conducting preclinical and clinical studies basic research multinutrient
functional-peptide complexes:

P.L. Shupyk National Medical Academy of Postgraduate Education

O.O.Bogomolets National Medical University

F.G. Yanovsky National Institute of Phthisiology and Pulmonology

A.M. Gorky
Donetsk National Medical University

Kyiv Children's City Gastroenterological Center

Figure-Freedom to live

Relive Balance® recommended by experts

The effectiveness of Relive Balance® complexes has been studied and confirmed by the work of experts from leading research institutes in Ukraine.

Patents and Proceedings
clinical research

"Method of treating thrombocytopenia in combination with viral hepatitis"

PATENT №36417

Patent for utility model
№ 36417, 27.10.2008

"Method of treating metabolic syndrome"

PATENT №32825

Patent for utility model
№ 32825,  26.05.2008

"Method of treating non-alcoholic steatohepatitis in combination with intestinal dysbiosis"

PATENT №32826

Patent for utility model
№ 32826,  26.05.2008

"Method of increasing the body's protection against influenza infection"

PATENT №49515

Patent for utility model
№ 49515,  26.04.2010

"Method of treating viral pneumonia"

PATENT №53482

Patent for utility model
№ 53482,  11.10.2010

Methodical recommendations "Multinutrient functional-peptide complex Greening in clinical practice"

CERTIFICATE ID-33740854

ISO 22000:2005
№ 8О120.СУБХПХЛ.020.01-18,  23.03.2018

Report on the research conducted on the topic: "Research of hepatoprotective and antitoxic action of "Grin Pro I/Relive Balance Pro" multinutrient functional composition and "Grin Mix I/Relive Balance Mix" multinutrient functional composition dated 2010.

  • Head of clinical trials: Corresponding Member of the National Academy of Sciences, Academy of Medical Sciences of Ukraine, Doctor of Medical Sciences, Professor, Honored Worker of Science and Technology of Ukraine, Laureate of the State Prize of Ukraine, O.O.Bogomolets National Medical University, Department for Clinical Pharmacology,
    Chekman Ivan Serhiiovych.

Report on scientific and research activity: Study of anti-influenza effects of MNFC "Grinization"/"Relive Balance" in the simulation of severe infection using highly virulent strain A/PR/8/34 (H1N1) dated 2010.

  •  Heads of clinical trials: Doctor of Medical Sciences, Professor, Head of the Laboratory of Pathomorphology and Cytology, Laureate of the State Prize of Ukraine, A.A. Shalimov National Institute of Surgery and Transplantology, Academy of Medical Sciences of Ukraine,
    Homoliako Iryna Volodymyrivna.
  •  Candidate of Medical Sciences, Senior Scientific Researcher, Deputy Scientific Director, State Enterprise "I.I. Mechnikov Ukrainian Research Anti-Plague Institute" of the Ministry of Health of Ukraine, Odesa,
    Lozytskyi Victor Petrovych.

Research report, stage №2: Influence of the use of "Greening" / "Relive Balance" on the titers of infectious virus and bacterial contamination of the lungs, as well as on pathomorphological changes in the lungs and some other organs in modeling influenza infection in mice infection with highly virulent strain of virus A / PR / 8/34 (H1N1) 2010

  •  Heads of clinical trials: Doctor of Medical Sciences, Professor, Head of the Laboratory of Pathomorphology and Cytology, Laureate of the State Prize of Ukraine, A.A. Shalimov National Institute of Surgery and Transplantology, Academy of Medical Sciences of Ukraine,
    Homoliako Iryna Volodymyrivna.
  •  Candidate of Medical Sciences, Senior Scientific Researcher, Deputy Scientific Director, State Enterprise "I.I. Mechnikov Ukrainian Research Anti-Plague Institute" of the Ministry of Health of Ukraine, Odesa,
    Lozytskyi Victor Petrovych.

Report on the results of study dated 2010 under the agreement on joint research activities between A.A. Shalimov National Institute of Surgery and Transplantology (NIST), Academy of Medical Sciences of Ukraine and the State Enterprise "I.I. Mechnikov Ukrainian Research Anti-Plague Institute" of the Ministry of Health of Ukraine, Purpose of the study: "Identification of the protective effect of different doses of MNFC "Grinization"/"Relive Balance" in treatment regimen of use of the complex in experimental influenza.

  • Heads of clinical trials: Doctor of Medical Sciences, Professor, Head of the Laboratory of Pathomorphology and Cytology, Laureate of the State Prize of Ukraine, A.A. Shalimov National Institute of Surgery and Transplantology, Academy of Medical Sciences of Ukraine,
    Homoliako Iryna Volodymyrivna.
  •  Candidate of Medical Sciences, Senior Scientific Researcher, Deputy Scientific Director, State Enterprise "I.I. Mechnikov Ukrainian Research Anti-Plague Institute" of the Ministry of Health of Ukraine, Odesa,
    Lozytskyi Victor Petrovych.

Publication on the research conducted on the topic: "Grinization"/"Relive Balance" as a method of rehabilitation in patients with malignant neoplasms in 2008

  • Head of clinical trials: Doctor of Medical Sciences, Professor, Honored Worker of Science and Technology of Ukraine, P.L. Shupyk National Medical Academy of Postgraduate Education,
    Miasoiedov Dmytro Volodymyrovych.

Publication "Therapeutic approaches to the treatment of chronic pancreatitis with underlying obesity using MNFC "Grinization"/"Relive Balance" dated 2008.

  • Head of clinical trials: Doctor of Medical Sciences, Professor, Head of the Department for Internal Medicine, M. Gorkyi Donetsk National Medical University, Head of Donetsk regional branch of the Ukrainian Gastroenterological Association,
    Gubergryts Nataliia Borysivna.
  • Master's degree student of the Department for Internal Medicine No.1 of M. Gorkyi Donetsk National Medical University,
    Beliiaieva Nadezhda Volodymyrivna.

Randomized clinical trial "Report on the study of the effectiveness and tolerability of multinutrient functional composition" Grinization "/" Relive Balance "in patients with pulmonary tuberculosis" 2008

  • Head of clinical trials: Doctor of Medical Sciences, Professor, State Enterprise "F.G. Yanovskyi National Institute of Tuberculosis and Pulmonology", Academy of Sciences of Ukraine,
    Cherenko Svetlana Alexandrovna.

"Study of AIDS patients" conducted in 2008

  • Head of clinical trials: Chief Physician, Kyiv Municipal Tuberculosis Hospital No.1,
    Stadnik Leonid Vasyliovych.

Report on clinical trials: "Open-label trial of efficacy of MNFC "Grinization"/"Relive Balance", as a pathogenetic agent, compared with standard vitamin hepatoprotection in treatment of pulmonary tuberculosis in children" dated 2008.

  • Head of clinical trials: Doctor of Medical Sciences, Professor, State Enterprise "F.G. Yanovskyi National Institute of Tuberculosis and Pulmonology", Academy of Sciences of Ukraine,
    Kostromina Victoriia Pavlivna.

Report on research work on the topic № 06, BF 036-14 "Study of cytoprotective, antioxidant and immunomodulatory properties of drugs" Green Mix / Relive Balance Mix "and" Green Pro / Relive Balance Pro "on an experimental model of toxic hepatitis" 2007

  • Scientific adviser: Ph.D., Professor, Chairman of the Methodical Commission on Biology of the Ministry of Education and Science of Ukraine, Chairman of the Specialized Academic Council for the Defense of Doctoral Dissertations in Radiobiology, Biochemistry, Plant Physiology, Ecology, Taras Shevchenko National University of Kyiv, Faculty of Biology
    Ostapchenko Lyudmila Ivanivna.

Report on a clinical open-label trial to study the efficacy and tolerability of functional nutrition using "Grinization"/"Relive Balance" in patients with chronic toxic hepatitis, conducted at the Department for Gastroenterology, Dietetics and Endoscopy" dated 2007

  • Heads of clinical trials: Doctor of Medical Sciences, Professor, Chief Specialist in "Gastroenterology" of the Ministry of Health of Ukraine, Deputy Head of Department for Gastroenterology, Dietetics and Endoscopy, P.L. Shupyk National Medical Academy of Postgraduate Education
    Kharchenko Nataliia Viacheslavivna.
  • Doctor of Medical Sciences, Professor, Honored Doctor of Ukraine, Outstanding teacher in Education, P.L. Shupyk National Medical Academy of Postgraduate Education
    Anokhina Halyna Anatoliivna.

Report on a clinical trial to study the efficacy and tolerability of "GRINIZATION"/"Relive Balance" multinutrient functional composition in patients with hypertension with metabolic syndrome, in patients with type II diabetes in 2007.

  • Head of clinical trial: Candidate of Medical Sciences, Senior Scientific Researcher, Head of the Central Research Laboratory of P.L. Shupyk National Medical Academy of Postgraduate Education, Ministry of Health of Ukraine
    Ihrunova Kseniia Mykolaiivna.

Research report: "Study of the peculiarities of changes in the body's immune system in chronic viral and autoimmune hepatitis and development of schemes for the use of multinutrient functional-peptide complex" Grinization "/" Relive Balance "2007

  • Head of Clinical Research: Doctor of Medicine, Professor, Honored Scientist, Head of the Department of Neuroimmunology, Academy of Medical Sciences of Ukraine, Institute of Neurosurgery, Department of Neuroimmunology
    Linnyk Mykola Ivanovych.

Research report "Use of multinutrient functional - peptide complex" Grinization "/" Relive Balance "in the treatment of chronic hepatitis" 2007

  • Head of clinical research: Candidate of Medical Sciences, National Medical University named after OO Bogomolets of the Ministry of Health of Ukraine
    Pechinka Anatoliy Mykhailovych.

Report on clinical testing of multinutrient functional-peptide complexes (MFPC) in the treatment of patients with chronic hepatitis in 2006

  • Head of clinical research: Candidate of Medical Sciences, Head of the Kyiv Children's Gastroenterological Center
    Zaitseva Nadiya Yevhenivna.

Research report: "Study of metabolic disorders in patients with malignant neoplasms, chronic hepatitis of various etiologies and metabolic syndrome (syndrome X) and the results of multinutrient functional complexes" Grin pro / "Grin pro" / "Relive Balance Pro", "Grin mix" Relive Balance Mix , "Grin caps") for their correction "2006

  • Head of clinical trials: Doctor of Medical Sciences, Professor, State Enterprise "F.G. Yanovskyi National Institute of Tuberculosis and Pulmonology", Academy of Sciences of Ukraine,
    Linnyk Mykola Ivanovych.

Information letters about innovations in the health care system of Ukraine

1

Information letter "Therapeutic and prophylactic action of multinutrient functional-peptide complex (MNPK) in acute respiratory viral infections".

2

Information letter "New possibilities for the treatment of patients with chronic pancreatitis on the background of obesity"

3

Information sheet "Type 2 diabetes mellitus in combination with hypertension: pathogenetic correction of metabolism by multinutrient functional-peptide complex" Greening "

4

Information letter "Correction of metabolism in patients with hypertension and metabolic syndrome by multinutrient functional-peptide composition"